Legal Representation
Attorney
Lori N. Boatright
USPTO Deadlines
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 27, 2008 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 27, 2008 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 4, 2008 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 4, 2008 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 4, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 18, 2007 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 20, 2007 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 20, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 6, 2007 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 12, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 22, 2006 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Oct 18, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Oct 13, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 11, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 10, 2006 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Sep 20, 2006 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 25, 2006 | I | PAPER RECEIVED | Loading... | |
| Mar 20, 2006 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
| Mar 17, 2006 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Nov 8, 2005 | DMCC | I | DATA MODIFICATION COMPLETED | Loading... |
| Oct 31, 2005 | I | PAPER RECEIVED | Loading... | |
| Apr 28, 2005 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Apr 27, 2005 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 19, 2005 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 27, 2004 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical research and development services
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
NARYX PHARMACEUTICAL
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMA"